Table 2.
Patients (n = 140) | Controls (n = 159) | P‐value | |
---|---|---|---|
Gender(male/female) | 51/89 | 61/98 | 0.730 |
Age (y) | 59.00 (50.00, 65.00) | 62.00 (42.00, 67.00) | 0.139 |
WBC (×109/L) | 6.39 (4.88, 8.96) | 6.29 (5.61, 7.28) | 0.937 |
RBC (×1012/L) | 3.87 ± 0.80 | 4.53 ± 0.29 | 0.000 |
HGB (g/L) | 103.44 ± 24.96 | 135.48 ± 8.31 | 0.000 |
MCV (fL) | 86.88 (73.42, 91.78) | 90.04 (87.51, 92.22) | 0.000 |
MCH (pg) | 28.36 (22.96, 30.40) | 29.91 (29.04, 30.82) | 0.000 |
MCHC (g/L) | 325.05 (312.50, 332.15) | 332.80 (329.00, 335.80) | 0.000 |
PLT (×109/L) | 255.30 (209.62, 320.10) | 232.30 (206.70, 260.90) | 0.002 |
NEU (×109/L) | 3.64 (2.59, 5.33) | 3.58 (2.93, 4.13) | 0.327 |
LYM (×109/L) | 1.36 (1.06, 1.87) | 2.15 (1.86, 2.40) | 0.000 |
EOS (×109/L) | 0.35 (0.15, 0.72) | 0.11 (0.07, 0.20) | 0.000 |
NLR | 2.60 (1.63, 4.47) | 1.61 (1.36, 2.06) | 0.000 |
PLR | 171.52 (129.74, 269.48) | 106.83 (90.00, 131.76) | 0.000 |
ELR | 0.26 (0.13, 0.48) | 0.06 (0.03, 0.09) | 0.000 |
ELR, eosinophil‐to‐lymphocyte ratio; EOS, eosinophils; HGB, hemoglobin; LYM, lymphocytes; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; NEU, neutrophils; NLR, neutrophil‐to‐lymphocyte ratio; Patients, ancylostomiasis patients; PLR, platelet‐to‐lymphocyte ratio; PLT, platelet count; RBC, red blood cells; WBC, white blood cells.